Evidence map›Paper›PMID 38910897›Full record

ArticleDementia and geriatric cognitive disorders extra

Primary Microgliopathy Presenting as Degenerative Dementias: A Case Series of Novel Gene Mutations from India.

Subasree Ramakrishnan, Faheem Arshad, Keerthana Bs, Arun Gokul Pon, Susan Bosco, Sandeep Kumar, Hariharakrishnan Chidambaram, Subhash Chandra Bose Chinnathambi, Karthik Kulanthaivelu, Gautham Arunachal and 1 more

Abstract read
In one paragraph

Article in Dementia and geriatric cognitive disorders extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. CSF1R-related disorder: A clinical, imaging and genetic profile review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Subasree RamakrishnanDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Faheem ArshadDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Keerthana BsDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Arun Gokul PonDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Susan BoscoDepartment of Human Genetics, NIMHANS, Bengaluru, India.
Sandeep KumarDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Hariharakrishnan ChidambaramDepartment of Neurochemistry, NIMHANS, Bengaluru, India.
Subhash Chandra Bose ChinnathambiDepartment of Neurochemistry, NIMHANS, Bengaluru, India.
Karthik KulanthaiveluDepartment of Neuroimaging and Interventional Radiology, NIMHANS, Bengaluru, India.
Gautham ArunachalDepartment of Human Genetics, NIMHANS, Bengaluru, India.
Suvarna AlladiDepartment of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Microglia exert a crucial role in homeostasis of white matter integrity, and several studies highlight the role of microglial dysfunctions in neurodegeneration. Primary microgliopathy is a disorder where the pathogenic abnormality of the microglia causes white matter disorder and leads to a neuropsychiatric disease. Triggering receptor expressed on myeloid cells ( Methods: The prospective study was conducted in a university referral hospital in South India, as a part of an ongoing clinico-genetic research on dementia subjects, and was approved by the Institutional Ethics Committee. All patients underwent detailed assessment including sociodemographic profile, clinical and cognitive assessment, pedigree analysis and comprehensive neurological examination. Subjects consenting for blood sampling underwent genetic testing by whole-exome sequencing (WES). Results: A total of 100 patients with dementia underwent genetic analysis using WES and three pathogenic variants, one each of Conclusion: WES has widened the spectrum of underlying neuropathology of degenerative dementias, and diagnosing primary microglial dysfunction with emerging therapeutic options is of paramount importance. The cases of primary microgliopathy due to novel mutations in

Indexed as

Alzheimer’s dementiaFrontotemporal dementiaMicrogliopathyWhole exome sequencing

Identifiers

PMID38910897
PMCPMC11192518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.